LANIER BIOTHERAPEUTICS Trademark

Trademark Overview


On Tuesday, October 5, 2021, a trademark application was filed for LANIER BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the LANIER BIOTHERAPEUTICS trademark a serial number of 97059971. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 22, 2024. This trademark is owned by Lanier Biotherapeutics, Inc. The LANIER BIOTHERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the treatment or prevention of dermatological, oncological, autoimmune, respiratory, inflammatory and ocular diseases, disorders and conditions; therapeutic preparations for the treatment or prevention of dermatological, oncological, autoimmune, respiratory, inflammatory and ocular diseases, disorders and conditions; biological preparations for the treatment or prevention of dermatological, oncological, autoimmune, respiratory, inflammatory and ocular diseases, disorders and conditions; ophthalmic preparations

Scientific, medical and pharmaceutical research and development services; research and development in the pharmaceutical and biotechnology fields; research and development of biologics; research and development services in the field of antibodies; medical and scientific research, namely, conducting clinical trials and testing services; information, advisory and consultancy services in relation to all of the foregoing
lanier biotherapeutics

General Information


Serial Number97059971
Word MarkLANIER BIOTHERAPEUTICS
Filing DateTuesday, October 5, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements


Description of MarkThe mark consists of two curved members converging above and to left of the letter "L" in the word "Lanier", which is in initial caps above the word "BIOTHERAPEUTICS" in all caps.
Goods and ServicesPharmaceuticals for the treatment or prevention of dermatological, oncological, autoimmune, respiratory, inflammatory and ocular diseases, disorders and conditions; therapeutic preparations for the treatment or prevention of dermatological, oncological, autoimmune, respiratory, inflammatory and ocular diseases, disorders and conditions; biological preparations for the treatment or prevention of dermatological, oncological, autoimmune, respiratory, inflammatory and ocular diseases, disorders and conditions; ophthalmic preparations
NOT AVAILABLE"BIOTHERAPEUTICS"
Goods and ServicesScientific, medical and pharmaceutical research and development services; research and development in the pharmaceutical and biotechnology fields; research and development of biologics; research and development services in the field of antibodies; medical and scientific research, namely, conducting clinical trials and testing services; information, advisory and consultancy services in relation to all of the foregoing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 29, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLanier Biotherapeutics, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBogart, GA 30622

Party NameLanier Biotherapeutics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBogart, GA 30622

Trademark Events


Event DateEvent Description
Saturday, October 30, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, October 8, 2021NEW APPLICATION ENTERED
Friday, October 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 8, 2022ASSIGNED TO EXAMINER
Wednesday, July 20, 2022EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, July 20, 2022COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Wednesday, July 20, 2022EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, July 20, 2022NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, September 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 16, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 16, 2023SOU EXTENSION 1 FILED
Friday, June 16, 2023SOU EXTENSION 1 GRANTED
Tuesday, June 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 18, 2023SOU EXTENSION 2 FILED
Monday, December 18, 2023SOU EXTENSION 2 GRANTED
Wednesday, December 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 22, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 22, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 18, 2023SOU TEAS EXTENSION RECEIVED